Novavax (NVAX) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Marco Green
May 10, 2018

The company's earnings will usually have a direct relationship to the price of the company's stock.

Energy stocks are up 12% in the past month, the best in the S&P 500. For the past 5 years, The Company's EPS growth has been almost -23.70%.

Shares of Novavax Inc (NASDAQ:NVAX) now have an Average Brokerage Recommendation of 2.25, number of Recs in ABR is 8 while industry rank of the company by ABR is out of 265.

NVAX traded up $0.09 during midday trading on Wednesday, hitting $1.71. The company's stock had a trading volume of 64,031 shares, compared to its average volume of 6,552,225. Initiated the stock rating on Novavax, a Buy. The stock has a market capitalization of $636.82 Million however its outstanding shares are 372.41 Million. The recent trading activity revealed that the stock price is at 121.92% off from its 52-week low and traded with move of -41.09% from high printed in the last 52-week period. For the stock, price target value has been calculated at $3.93.

Millennium Management LLC reduced its holdings in Novavax (NASDAQ:NVAX) by 72.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). During the past three months the stock gain -18.18%, however six months performance of the stock remained at 51.33%. During the yearly overview it upgraded 120.71% and Showed 30.65% year to date performance. The stock "NVAX" was trading at a distance of 1.23% from 20 days simple moving average, and its distance from 50 days simple moving average is -11.67% while it has a distance of 13.66% from the 200 days simple moving average. The volatility change in the previous week has observed by 6.02% and experienced of 5.38% change in the last month. The company's beta value stood at 2.47. Ladenburg Thalmann raised their price objective on Novavax to $2.50 and gave the stock a "buy" rating in a research note on Thursday, January 11th. As per Zacks simplified descending rating scale the ABR rank is displayed in the range of 1 to 5 where 1 represents Strong Buy and 5 a Strong Sell.

Shares of Novavax stock opened at $1.80 on Tuesday. Millennium Management LLC owned about 0.37% of Novavax worth $1,503,000 at the end of the most recent quarter. On a percent-of-sales basis, NVAX's free cash flow was -0.13% while FIT converted -0.13% of its revenues into cash flow. The company has a debt-to-equity ratio of -3.12, a quick ratio of 2.76 and a current ratio of 2.76. Total debt to equity ratio of the company for most recent quarter is N/A whereas long term debt to equity ratio for most recent quarter is N/A. Novavax, Inc. Return on equity (ROE) recorded at 278.40%. (NYSE:FIT), so far this year is at -0.35%. Generally speaking, if the indicator rises above -20, the shares may be overbought. Finally, Schwab Charles Investment Management Inc. raised its position in Novavax by 17.8% in the 4th quarter.

Welbilt, Inc. (NYSE:WBT) has seen its SMA20 which is now -0.42%. It shifted -16.94% down its 50-day simple moving average.

Volume analysis is used by technical analysts to determine the strength of price movement, as some believe price follows volume. This stock's distance from its 20-day simple moving average is 1.23%, based on a recent bid, while its distance from the 50-day simple moving average is now -11.67%. Whereas 3 of them predict the stock is a hold. Today, this organization is sitting -37.82% away from its 52-week high price and 119.40% away from its 52-week low price. The range is measured the same way for options and commodities - high minus low - as they are for stocks.

If the answer is less than 1, it indicates that price of the stock is in losing momentum. EchoStar Corporation (SATS) negotiated 334,988 shares and maintained an average volume of 228.92K shares. At the present, they have a price target for the Biotechnology set at $5. Calculating the market cap is easy. The company is estimating to achieve earnings per share (EPS) growth of 39.30% in this year and the earnings per share (EPS) growth expected to be 3.60% in the next year. Using this metric, investors can gauge whether high-growth stocks may be undervalued, even if they don't appear so with the more common P/E ratio.

The ability to consistently grow earnings at a high compound rate is a defining characteristic of the best companies for long-term investment. Given that earnings are what matter most to investors, analysts tend to place a greater weight on the P/E.

A negative PEG ratio does not imply that the stock is a bad investment.

NVAX has a PEG ratio of N/A, WBT has a PEG ratio of 1.31 and SATS has a PEG ratio of 12.15.

Other reports by Click Lancashire

Discuss This Article